D. L. Heene

3.3k total citations
134 papers, 2.5k citations indexed

About

D. L. Heene is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. L. Heene has authored 134 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 35 papers in Pulmonary and Respiratory Medicine and 31 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D. L. Heene's work include Blood properties and coagulation (31 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Venous Thromboembolism Diagnosis and Management (19 papers). D. L. Heene is often cited by papers focused on Blood properties and coagulation (31 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Venous Thromboembolism Diagnosis and Management (19 papers). D. L. Heene collaborates with scholars based in Germany, United States and Japan. D. L. Heene's co-authors include Job Harenberg, G. Stehle, Fritz Reinhard Matthias, W. Maier‐Borst, C.‐E. Dempfle, Andreas Wunder, G. Hartung, Hannsjörg Sinn, H. G. Lasch and P. Roebruck and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Hepatology.

In The Last Decade

D. L. Heene

125 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. L. Heene Germany 27 733 673 604 552 538 134 2.5k
Steven R. Deitcher United States 32 1.6k 2.2× 1.2k 1.8× 1.0k 1.7× 366 0.7× 803 1.5× 107 3.8k
James C. Fredenburgh Canada 34 558 0.8× 757 1.1× 1.4k 2.3× 654 1.2× 461 0.9× 79 3.4k
J. Dawes United Kingdom 30 473 0.6× 727 1.1× 891 1.5× 615 1.1× 690 1.3× 133 3.4k
Ingo Ahrens Germany 29 396 0.5× 887 1.3× 406 0.7× 247 0.4× 487 0.9× 98 2.7k
H. L. Nossel United States 29 325 0.4× 550 0.8× 1.8k 3.1× 1.4k 2.5× 335 0.6× 71 3.5k
John L. Francis United States 23 707 1.0× 364 0.5× 996 1.6× 251 0.5× 716 1.3× 75 2.6k
William P. Fay United States 39 500 0.7× 1.1k 1.6× 1.8k 3.0× 999 1.8× 686 1.3× 93 5.5k
Alan R. Stafford Canada 32 256 0.3× 380 0.6× 935 1.5× 412 0.7× 316 0.6× 74 2.6k
Mats Rånby Sweden 27 238 0.3× 433 0.6× 1.4k 2.3× 968 1.8× 337 0.6× 53 3.1k
N. Heimburger Germany 25 194 0.3× 216 0.3× 924 1.5× 453 0.8× 237 0.4× 93 2.5k

Countries citing papers authored by D. L. Heene

Since Specialization
Citations

This map shows the geographic impact of D. L. Heene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. L. Heene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. L. Heene more than expected).

Fields of papers citing papers by D. L. Heene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. L. Heene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. L. Heene. The network helps show where D. L. Heene may publish in the future.

Co-authorship network of co-authors of D. L. Heene

This figure shows the co-authorship network connecting the top 25 collaborators of D. L. Heene. A scholar is included among the top collaborators of D. L. Heene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. L. Heene. D. L. Heene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huhle, G., C. Abletshauser, Nóra Mayer, et al.. (1999). Reduction of Platelet Activity Markers in Type II Hypercholesterolemic Patients by a HMG-CoA-Reductase Inhibitor. Thrombosis Research. 95(5). 229–234. 89 indexed citations
2.
Müller, Alexander, et al.. (1999). Serious bleeding in a haemodialysis patient treated with recombinant hirudin. Nephrology Dialysis Transplantation. 14(10). 2482–2483. 6 indexed citations
3.
Stehle, G., et al.. (1999). Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats. Anti-Cancer Drugs. 10(4). 405–412. 15 indexed citations
4.
Harenberg, Job, et al.. (1997). Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Type II. Seminars in Thrombosis and Hemostasis. 23(2). 189–196. 45 indexed citations
5.
Stehle, G., Andreas Wunder, Hannsjörg Sinn, et al.. (1997). Pharmacokinetics of methotrexate???albumin conjugates in tumor-bearing rats. Anti-Cancer Drugs. 8(9). 835–844. 59 indexed citations
6.
Harenberg, Job, et al.. (1997). Measurement of Fluorescent-Labeled LMM-Heparin in Biological Fluids Using Protamine-Linked Microbeads. Seminars in Thrombosis and Hemostasis. 23(1). 23–30. 1 indexed citations
7.
Harenberg, Job, et al.. (1997). Long-Term Anticoagulation of Outpatients with Adverse Events to Oral Anticoagulants Using Low-Molecular-Weight Heparin. Seminars in Thrombosis and Hemostasis. 23(2). 167–172. 40 indexed citations
8.
Harenberg, Job, et al.. (1997). Comparison of the Pharmacodynamic and Pharmacokinetic Profiles of Two Low-Molecular-Mass Heparins in Rats. Seminars in Thrombosis and Hemostasis. 23(2). 109–117. 3 indexed citations
9.
Stehle, G., Hannsjörg Sinn, Andreas Wunder, et al.. (1997). Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia. Critical Reviews in Oncology/Hematology. 26(2). 77–100. 250 indexed citations
10.
Harenberg, Job, P. Roebruck, & D. L. Heene. (1996). Subcutaneous Low-Molecular-Weight Heparin versus Standard Heparin and the Prevention of Thromboembolism in Medical Inpatients. Pathophysiology of Haemostasis and Thrombosis. 26(3). 127–139. 116 indexed citations
11.
Harenberg, Job, et al.. (1996). Chromatographic and electrophoretic applications for the analysis of heparin and dermatan sulfate. Journal of Chromatography B Biomedical Sciences and Applications. 685(2). 223–231. 26 indexed citations
12.
Wunder, A., G. Stehle, H. Sinn, et al.. (1995). The injection of heparin prolongs the plasma clearance of oxidized low density lipoprotein in the rat. Thrombosis Research. 78(2). 139–149. 5 indexed citations
13.
Harenberg, Job, et al.. (1995). Magnetic bead protamine-linked microtiter assay for detection of heparin using iodinated low-molecular-mass heparin-tyramine. Thrombosis Research. 79(2). 207–216. 4 indexed citations
14.
Harenberg, Job, et al.. (1994). Competitive Binding of Low Molecular Mass Heparin-Tyramine Fluorescein-5-Isothiocyanate and Unlabeled Glycosaminoglycans to Leukocytes. Seminars in Thrombosis and Hemostasis. 20(3). 236–244. 3 indexed citations
15.
Harenberg, Job, et al.. (1994). Semisynthesis and Analysis of Lipophilically Modified Unfractionated and Low Molecular Mass Heparins. Seminars in Thrombosis and Hemostasis. 20(2). 182–192. 2 indexed citations
16.
Stehle, G., E. Friedrich, H. Sinn, et al.. (1992). Hepatic uptake of a modified low molecular weight heparin in rats.. Journal of Clinical Investigation. 90(5). 2110–2116. 20 indexed citations
17.
Harenberg, Job & D. L. Heene. (1988). Pharmacology and special clinical applications of low‐molecular‐weight heparins. American Journal of Hematology. 29(4). 233–240. 15 indexed citations
18.
Buss, J., et al.. (1988). Ventricular function in cirrhosis and portasystemic shunt: A two-dimensional echocardiographic study. Hepatology. 8(3). 658–662. 30 indexed citations
19.
Hoffmann, Ursula, et al.. (1987). Hereditary angioedema and aortitis. Journal of Molecular Medicine. 65(18). 885–887.
20.
Lasch, H. G., L Róka, & D. L. Heene. (1965). Defibrination syndrome.. BMJ. 2(5468). 955–956. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven R. Deitcher Breakdown of academic impact, for papers by James C. Fredenburgh Breakdown of academic impact, for papers by J. Dawes Breakdown of academic impact, for papers by Ingo Ahrens Breakdown of academic impact, for papers by H. L. Nossel Breakdown of academic impact, for papers by John L. Francis Breakdown of academic impact, for papers by William P. Fay Breakdown of academic impact, for papers by Alan R. Stafford Breakdown of academic impact, for papers by Mats Rånby Breakdown of academic impact, for papers by N. Heimburger
Rankless by CCL
2026